Cargando…
Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activit...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060870/ https://www.ncbi.nlm.nih.gov/pubmed/21445272 http://dx.doi.org/10.1371/journal.pone.0017441 |
_version_ | 1782200554895704064 |
---|---|
author | Hemmert, Andrew C. Otto, Tamara C. Chica, Roberto A. Wierdl, Monika Edwards, Jonathan S. Lewis, Steven L. Edwards, Carol C. Tsurkan, Lyudmila Cadieux, C. Linn Kasten, Shane A. Cashman, John R. Mayo, Stephen L. Potter, Philip M. Cerasoli, Douglas M. Redinbo, Matthew R. |
author_facet | Hemmert, Andrew C. Otto, Tamara C. Chica, Roberto A. Wierdl, Monika Edwards, Jonathan S. Lewis, Steven L. Edwards, Carol C. Tsurkan, Lyudmila Cadieux, C. Linn Kasten, Shane A. Cashman, John R. Mayo, Stephen L. Potter, Philip M. Cerasoli, Douglas M. Redinbo, Matthew R. |
author_sort | Hemmert, Andrew C. |
collection | PubMed |
description | Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activity into the human drug metabolism enzyme carboxylesterase 1. Using crystal structures of the target enzyme in complex with nerve agent as a guide, a pair of histidine and glutamic acid residues were designed proximal to the enzyme's native catalytic triad. The resultant variant protein demonstrated significantly increased rates of reactivation following exposure to sarin, soman, and cyclosarin. Importantly, the addition of these residues did not alter the high affinity binding of nerve agents to this protein. Thus, using two amino acid substitutions, a novel enzyme was created that efficiently converted a group of hemisubstrates, compounds that can start but not complete a reaction cycle, into bona fide substrates. Such approaches may lead to novel countermeasures for nerve agent poisoning. |
format | Text |
id | pubmed-3060870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30608702011-03-28 Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme Hemmert, Andrew C. Otto, Tamara C. Chica, Roberto A. Wierdl, Monika Edwards, Jonathan S. Lewis, Steven L. Edwards, Carol C. Tsurkan, Lyudmila Cadieux, C. Linn Kasten, Shane A. Cashman, John R. Mayo, Stephen L. Potter, Philip M. Cerasoli, Douglas M. Redinbo, Matthew R. PLoS One Research Article Organophosphorus (OP) nerve agents are potent suicide inhibitors of the essential neurotransmitter-regulating enzyme acetylcholinesterase. Due to their acute toxicity, there is significant interest in developing effective countermeasures to OP poisoning. Here we impart nerve agent hydrolysis activity into the human drug metabolism enzyme carboxylesterase 1. Using crystal structures of the target enzyme in complex with nerve agent as a guide, a pair of histidine and glutamic acid residues were designed proximal to the enzyme's native catalytic triad. The resultant variant protein demonstrated significantly increased rates of reactivation following exposure to sarin, soman, and cyclosarin. Importantly, the addition of these residues did not alter the high affinity binding of nerve agents to this protein. Thus, using two amino acid substitutions, a novel enzyme was created that efficiently converted a group of hemisubstrates, compounds that can start but not complete a reaction cycle, into bona fide substrates. Such approaches may lead to novel countermeasures for nerve agent poisoning. Public Library of Science 2011-03-18 /pmc/articles/PMC3060870/ /pubmed/21445272 http://dx.doi.org/10.1371/journal.pone.0017441 Text en Hemmert et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hemmert, Andrew C. Otto, Tamara C. Chica, Roberto A. Wierdl, Monika Edwards, Jonathan S. Lewis, Steven L. Edwards, Carol C. Tsurkan, Lyudmila Cadieux, C. Linn Kasten, Shane A. Cashman, John R. Mayo, Stephen L. Potter, Philip M. Cerasoli, Douglas M. Redinbo, Matthew R. Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme |
title | Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme |
title_full | Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme |
title_fullStr | Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme |
title_full_unstemmed | Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme |
title_short | Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme |
title_sort | nerve agent hydrolysis activity designed into a human drug metabolism enzyme |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060870/ https://www.ncbi.nlm.nih.gov/pubmed/21445272 http://dx.doi.org/10.1371/journal.pone.0017441 |
work_keys_str_mv | AT hemmertandrewc nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT ottotamarac nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT chicarobertoa nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT wierdlmonika nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT edwardsjonathans nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT lewisstevenl nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT edwardscarolc nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT tsurkanlyudmila nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT cadieuxclinn nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT kastenshanea nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT cashmanjohnr nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT mayostephenl nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT potterphilipm nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT cerasolidouglasm nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme AT redinbomatthewr nerveagenthydrolysisactivitydesignedintoahumandrugmetabolismenzyme |